Literature DB >> 9689964

[Adjuvant or therapeutic androgen suppression in locoregional advanced prostatic carcinoma (RTOG 85-31)].

W Hinkelbein.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1998        PMID： 9689964     DOI： 10.1007/bf03038357

Source DB:  PubMed          Journal:  Strahlenther Onkol        ISSN： 0179-7158            Impact factor:   3.621


× No keyword cloud information.
  5 in total

1.  Improved survival in patients with locally advanced prostate cancer treated with radiotherapy and goserelin.

Authors:  M Bolla; D Gonzalez; P Warde; J B Dubois; R O Mirimanoff; G Storme; J Bernier; A Kuten; C Sternberg; T Gil; L Collette; M Pierart
Journal:  N Engl J Med       Date:  1997-07-31       Impact factor: 91.245

2.  Phase III trial of androgen suppression using goserelin in unfavorable-prognosis carcinoma of the prostate treated with definitive radiotherapy: report of Radiation Therapy Oncology Group Protocol 85-31.

Authors:  M V Pilepich; R Caplan; R W Byhardt; C A Lawton; M J Gallagher; J B Mesic; G E Hanks; C T Coughlin; A Porter; W U Shipley; D Grignon
Journal:  J Clin Oncol       Date:  1997-03       Impact factor: 44.544

3.  Androgen deprivation with radiation therapy compared with radiation therapy alone for locally advanced prostatic carcinoma: a randomized comparative trial of the Radiation Therapy Oncology Group.

Authors:  M V Pilepich; J M Krall; M al-Sarraf; M J John; R L Doggett; W T Sause; C A Lawton; R A Abrams; M Rotman; P Rubin
Journal:  Urology       Date:  1995-04       Impact factor: 2.649

4.  Hormonal treatment at time of radical retropubic prostatectomy for stage D1 prostate cancer: results of long-term followup.

Authors:  R P Myers; J J Larson-Keller; E J Bergstralh; H Zincke; J E Oesterling; M M Lieber
Journal:  J Urol       Date:  1992-03       Impact factor: 7.450

Review 5.  [Radiotherapy after radical prostatectomy: indications, results and side effects].

Authors:  T Wiegel; U Steiner; W Hinkelbein
Journal:  Strahlenther Onkol       Date:  1997-06       Impact factor: 4.033
  5 in total
  1 in total

1.  Early versus deferred standard androgen suppression therapy for advanced hormone-sensitive prostate cancer.

Authors:  Frank Kunath; Katrin Jensen; Mariona Pinart; Andreas Kahlmeyer; Stefanie Schmidt; Carrie L Price; Verena Lieb; Philipp Dahm
Journal:  Cochrane Database Syst Rev       Date:  2019-06-11
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.